New York, NY, United States of America

Yang Fei


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Yang Fei in Ocular Devices

Introduction

Yang Fei is an innovative inventor based in New York, NY, who has made significant contributions to the field of ocular devices. With a focus on enhancing medical technology, he has developed a unique patent that addresses the needs of individuals with specific medical conditions.

Latest Patents

Yang Fei holds a patent for "Ocular devices and methods for the employment thereof." This invention includes a device designed for placement into a lacrimal punctum or conjunctival sac of a person. The device incorporates one or more sensor materials that respond to various components of the chemical composition of a person's tears. Each sensor material is configured to present a tear-based color from a range of colors that indicate a medical condition. Notably, phenylboronic acid is mentioned as a potential sensor material, along with materials that emit radiation when excited by other radiation.

Career Highlights

Throughout his career, Yang Fei has demonstrated a commitment to advancing ocular technology. His work has led to the development of innovative solutions that can improve the quality of life for individuals with specific eye-related health issues. His patent reflects a deep understanding of both the medical and technological aspects of ocular devices.

Collaborations

Yang Fei has collaborated with notable professionals in his field, including Eugene Orloff and Paul Vannest Braun. These collaborations have likely contributed to the refinement and success of his inventions.

Conclusion

Yang Fei's contributions to ocular devices exemplify the intersection of innovation and healthcare. His patent showcases the potential for technology to address medical needs effectively. The advancements he has made in this field are commendable and highlight the importance of continued research and development in ocular technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…